Dunstan, Colin R.

Osteoprotegerin mitigates tail suspension-induced osteopenia.

Bateman, T. A., Dunstan, C. R., Ferguson, V. L., Lacey, D. L., Ayers, R. A., & Simske, S. J. (2000) · Bone

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 66

The effects of osteoprotegerin on the mechanical properties of rat bone.

Ross, A. B., Bateman, T. A., Kostenuik, P. J., Ferguson, V. L., Lacey, D. L., Dunstan, C. R., & Simske, S. J. (2001) · Journal of Materials Science: Materials in Medicine

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 39

A toxicity profile of osteoprotegerin in the cynomolgus monkey.

Smith, B. B., Cosenza, M. E., Mancini, A., Dunstan, C., Gregson, R., Martin, S. W., Smith, S. Y., & Davis, H. (2003) · International Journal of Toxicology

Bone Metabolism and DiseasesImmunotoxicology and immune responses

Cited by 33

The effect of long-term low-dose diphosphonate treatment on rat bone.

EVANS, R. A., HOWLETT, C. R., DUNSTAN, C. R., & HILLS, E. (1982) · Clinical Orthopaedics and Related Research

Bone Metabolism and DiseasesBone health and treatments

Cited by 32

Osteoprotegerin ameliorates sciatic nerve crush induced bone loss.

Bateman, T. A., Dunstan, C. R., Lacey, D. L., Ferguson, V. L., Ayers, R. A., & Simske, S. J. (2001) · Journal of Orthopaedic Research

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 22